INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

NYSE:INVX • US4576511079

26.53 USD
+0.18 (+0.68%)
At close: Mar 2, 2026
26.53 USD
0 (0%)
After Hours: 3/2/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to INVX. INVX was compared to 60 industry peers in the Energy Equipment & Services industry. INVX has an excellent financial health rating, but there are some minor concerns on its profitability. INVX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes INVX very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year INVX was profitable.
  • In the past year INVX had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: INVX reported negative net income in multiple years.
  • Of the past 5 years INVX 4 years had a positive operating cash flow.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • The Return On Assets of INVX (6.57%) is better than 81.67% of its industry peers.
  • With a decent Return On Equity value of 7.88%, INVX is doing good in the industry, outperforming 70.00% of the companies in the same industry.
  • INVX has a Return On Invested Capital of 8.28%. This is in the better half of the industry: INVX outperforms 71.67% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for INVX is significantly below the industry average of 13.23%.
  • The last Return On Invested Capital (8.28%) for INVX is above the 3 year average (5.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.57%
ROE 7.88%
ROIC 8.28%
ROA(3y)6.11%
ROA(5y)1.09%
ROE(3y)7.53%
ROE(5y)1.62%
ROIC(3y)5.11%
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • INVX's Profit Margin of 8.51% is fine compared to the rest of the industry. INVX outperforms 76.67% of its industry peers.
  • INVX has a Operating Margin of 11.63%. This is in the better half of the industry: INVX outperforms 61.67% of its industry peers.
  • With a decent Gross Margin value of 31.00%, INVX is doing good in the industry, outperforming 70.00% of the companies in the same industry.
  • INVX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.63%
PM (TTM) 8.51%
GM 31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.34%
GM growth 5Y3.49%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INVX is destroying value.
  • Compared to 1 year ago, INVX has about the same amount of shares outstanding.
  • INVX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, INVX has an improved debt to assets ratio.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • INVX has an Altman-Z score of 7.11. This indicates that INVX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of INVX (7.11) is better than 98.33% of its industry peers.
  • INVX has a debt to FCF ratio of 0.16. This is a very positive value and a sign of high solvency as it would only need 0.16 years to pay back of all of its debts.
  • INVX has a better Debt to FCF ratio (0.16) than 93.33% of its industry peers.
  • A Debt/Equity ratio of 0.02 indicates that INVX is not too dependend on debt financing.
  • INVX has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. INVX outperforms 88.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.16
Altman-Z 7.11
ROIC/WACC0.97
WACC8.51%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 4.91 indicates that INVX has no problem at all paying its short term obligations.
  • INVX's Current ratio of 4.91 is amongst the best of the industry. INVX outperforms 95.00% of its industry peers.
  • INVX has a Quick Ratio of 3.24. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
  • INVX has a Quick ratio of 3.24. This is amongst the best in the industry. INVX outperforms 93.33% of its industry peers.
Industry RankSector Rank
Current Ratio 4.91
Quick Ratio 3.24
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 335.29% over the past year.
  • Measured over the past years, INVX shows a very strong growth in Earnings Per Share. The EPS has been growing by 67.88% on average per year.
  • Looking at the last year, INVX shows a very strong growth in Revenue. The Revenue has grown by 26.86%.
  • INVX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.80% yearly.
EPS 1Y (TTM)335.29%
EPS 3YN/A
EPS 5Y67.88%
EPS Q2Q%-42.86%
Revenue 1Y (TTM)26.86%
Revenue growth 3Y39.3%
Revenue growth 5Y21.8%
Sales Q2Q%9.14%

3.2 Future

  • INVX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.77% yearly.
  • The Revenue is expected to grow by 4.22% on average over the next years.
EPS Next Y103.87%
EPS Next 2Y52.94%
EPS Next 3Y34.77%
EPS Next 5YN/A
Revenue Next Year3.75%
Revenue Next 2Y4.02%
Revenue Next 3Y4.22%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 33.16, INVX can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of INVX is on the same level as its industry peers.
  • INVX is valuated rather expensively when we compare the Price/Earnings ratio to 27.13, which is the current average of the S&P500 Index.
  • INVX is valuated correctly with a Price/Forward Earnings ratio of 16.27.
  • INVX's Price/Forward Earnings ratio is rather cheap when compared to the industry. INVX is cheaper than 86.67% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.11. INVX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 33.16
Fwd PE 16.27
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • INVX's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, INVX is valued cheaply inside the industry as 86.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.74
EV/EBITDA 9.39
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • INVX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • INVX has a very decent profitability rating, which may justify a higher PE ratio.
  • INVX's earnings are expected to grow with 34.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)0.49
EPS Next 2Y52.94%
EPS Next 3Y34.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for INVX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INNOVEX INTERNATIONAL INC

NYSE:INVX (3/2/2026, 8:04:00 PM)

After market: 26.53 0 (0%)

26.53

+0.18 (+0.68%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-23
Earnings (Next)N/A
Inst Owners47.97%
Inst Owner Change3.68%
Ins Owners1.52%
Ins Owner Change-4.75%
Market Cap1.83B
Revenue(TTM)978.25M
Net Income(TTM)83.30M
Analysts77.78
Price Target25.5 (-3.88%)
Short Float %N/A
Short Ratio7.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-51.28%
Min EPS beat(2)-62.53%
Max EPS beat(2)-40.04%
EPS beat(4)0
Avg EPS beat(4)-37.33%
Min EPS beat(4)-62.53%
Max EPS beat(4)-22.68%
EPS beat(8)1
Avg EPS beat(8)-137.99%
EPS beat(12)1
Avg EPS beat(12)-134.16%
EPS beat(16)3
Avg EPS beat(16)-74.21%
Revenue beat(2)2
Avg Revenue beat(2)16.02%
Min Revenue beat(2)8.43%
Max Revenue beat(2)23.61%
Revenue beat(4)3
Avg Revenue beat(4)8.69%
Min Revenue beat(4)-4.42%
Max Revenue beat(4)23.61%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)15.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.09%
Valuation
Industry RankSector Rank
PE 33.16
Fwd PE 16.27
P/S 1.87
P/FCF 11.74
P/OCF 9.58
P/B 1.73
P/tB 2.17
EV/EBITDA 9.39
EPS(TTM)0.8
EY3.02%
EPS(NY)1.63
Fwd EY6.15%
FCF(TTM)2.26
FCFY8.52%
OCF(TTM)2.77
OCFY10.44%
SpS14.19
BVpS15.34
TBVpS12.21
PEG (NY)0.32
PEG (5Y)0.49
Graham Number16.62
Profitability
Industry RankSector Rank
ROA 6.57%
ROE 7.88%
ROCE 10.15%
ROIC 8.28%
ROICexc 10.12%
ROICexgc 13.23%
OM 11.63%
PM (TTM) 8.51%
GM 31%
FCFM 15.92%
ROA(3y)6.11%
ROA(5y)1.09%
ROE(3y)7.53%
ROE(5y)1.62%
ROIC(3y)5.11%
ROIC(5y)N/A
ROICexc(3y)5.92%
ROICexc(5y)N/A
ROICexgc(3y)7.49%
ROICexgc(5y)N/A
ROCE(3y)6.27%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.34%
GM growth 5Y3.49%
F-Score7
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.16
Debt/EBITDA 0.11
Cap/Depr 57.84%
Cap/Sales 3.59%
Interest Coverage 111.19
Cash Conversion 109.41%
Profit Quality 187.02%
Current Ratio 4.91
Quick Ratio 3.24
Altman-Z 7.11
F-Score7
WACC8.51%
ROIC/WACC0.97
Cap/Depr(3y)69.66%
Cap/Depr(5y)61.2%
Cap/Sales(3y)4.45%
Cap/Sales(5y)4.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)335.29%
EPS 3YN/A
EPS 5Y67.88%
EPS Q2Q%-42.86%
EPS Next Y103.87%
EPS Next 2Y52.94%
EPS Next 3Y34.77%
EPS Next 5YN/A
Revenue 1Y (TTM)26.86%
Revenue growth 3Y39.3%
Revenue growth 5Y21.8%
Sales Q2Q%9.14%
Revenue Next Year3.75%
Revenue Next 2Y4.02%
Revenue Next 3Y4.22%
Revenue Next 5YN/A
EBIT growth 1Y26.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year78.72%
EBIT Next 3Y28.79%
EBIT Next 5YN/A
FCF growth 1Y95.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.32%
OCF growth 3YN/A
OCF growth 5YN/A

INNOVEX INTERNATIONAL INC / INVX FAQ

Can you provide the ChartMill fundamental rating for INNOVEX INTERNATIONAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVX.


Can you provide the valuation status for INNOVEX INTERNATIONAL INC?

ChartMill assigns a valuation rating of 6 / 10 to INNOVEX INTERNATIONAL INC (INVX). This can be considered as Fairly Valued.


What is the profitability of INVX stock?

INNOVEX INTERNATIONAL INC (INVX) has a profitability rating of 6 / 10.


How financially healthy is INNOVEX INTERNATIONAL INC?

The financial health rating of INNOVEX INTERNATIONAL INC (INVX) is 9 / 10.


Can you provide the dividend sustainability for INVX stock?

The dividend rating of INNOVEX INTERNATIONAL INC (INVX) is 0 / 10 and the dividend payout ratio is 0%.